This Article Full Text Full Text (PDF) All Versions of this Article: 91/5/1748    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Charopoulos, I. Articles by Lyritis, G. P. Search for Related Content PubMed PubMed Citation Articles by Charopoulos, I. Articles by Lyritis, G. P. Related Collections Calcium and Bone Metabolism Female Endocrinology

Effect of Primary Hyperparathyroidism on Volumetric Bone Mineral Density and Bone Geometry Assessed by Peripheral Quantitative Computed Tomography in Postmenopausal Women

Laboratory for Research of Musculoskeletal System (I.C., S.T., G.T., P.R., K.K., G.P.L.), University of Athens, KAT Hospital, 14561 Athens, Greece; Endocrinology Department (P.K.), Metaxa Hospital, 18537 Piraeus, Greece; and Metabolic Bone Disease Unit (G.S.), First Department of Orthopedics, University of Athens, Attikon Hospital, 12410 Athens, Greece

Address all correspondence and requests for reprints to: Symeon Tournis, M.D., Laboratory for Research of Musculoskeletal System "Th. Garofalidis," University of Athens, KAT Hospital, 10 Athinas Street, Kifissia, 14561, Athens, Greece. E-mail: stournis{at}med.uoa.gr.

Context: Primary hyperparathyroidism (PH) is characterized by inappropriate PTH elevation with or without hypercalcemia. Bone disease involves catabolic action at cortical sites, whereas cancellous sites and geometry might be relatively preserved.

Objective: Our objective was to examine the effect of PH on quantitative and qualitative bone characteristics using peripheral quantitative computed tomography at the tibia in postmenopausal women with PH and healthy controls.

Design and Setting: We conducted a cross-sectional study at a tertiary referral center.

Patients: Fifty-two postmenopausal women with PH and 56 healthy controls, comparable for age and anthropometric measures, participated.

Intervention: There was no intervention.

Main Outcome Measure: We assessed volumetric bone mineral density (vBMD), bone mineral content (BMC), cortical thickness, cortical and trabecular area, peri- and endosteal circumference, and polar stress strength index assessed by peripheral quantitative computed tomography of the left tibia at 4% (cancellous), 14% (transition zone), and 38% (cortical) from the distal end.

Results: At 4%, there was a significant decrease of trabecular BMC and vBMD (P < 0.001), effect particularly evident in hypercalcemic patients, whereas trabecular area was comparable. At 38%, cortical BMC (P < 0.01), vBMD (P < 0.01), area (P < 0.05), and thickness (P < 0.001) were reduced in the PH group, particularly in hypercalcemic patients. Endosteal circumference increased (P < 0.001), whereas periosteal circumference was comparable, indicating cancellization of cortical bone. At 14%, polar stress strength index was significantly decreased (P < 0.01) in hypercalcemic patients, indicating impairment of bone mechanical properties.

Conclusions: Normocalcemic PH is characterized by catabolic actions at both cortical and cancellous sites (38 and 4%, respectively), an effect accentuated in hypercalcemic patients. Cortical geometric properties are adversely affected even in normocalcemic patients, whereas trabecular properties are generally preserved.

This article has been cited by other articles:

				M. R. Rubin, J. P. Bilezikian, D. J. McMahon, T. Jacobs, E. Shane, E. Siris, J. Udesky, and S. J. Silverberg The Natural History of Primary Hyperparathyroidism with or without Parathyroid Surgery after 15 Years J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3462 - 3470. [Abstract] [Full Text] [PDF]

				R. Zoehrer, D. W. Dempster, J. P. Bilezikian, H. Zhou, S. J. Silverberg, E. Shane, P. Roschger, E. P. Paschalis, and K. Klaushofer Bone Quality determined by Fourier Transform Infrared Imaging Analysis in Mild Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3484 - 3489. [Abstract] [Full Text] [PDF]

				H. Kaji, M. Yamauchi, R. Nomura, and T. Sugimoto Improved Peripheral Cortical Bone Geometry after Surgical Treatment of Primary Hyperparathyroidism in Postmenopausal Women J. Clin. Endocrinol. Metab., August 1, 2008; 93(8): 3045 - 3050. [Abstract] [Full Text] [PDF]

				P. Yazgan, A. Ozturk, I. Orhan, O. Sirmatel, and F. Baba Third Metatarsal Brown Tumor with Secondary Hyperparathyroidism: An Atypical Localization J Am Podiatr Med Assoc, July 1, 2008; 98(4): 314 - 317. [Abstract] [Full Text] [PDF]

				E. C. Hsiao, B. M. Boudignon, W. C. Chang, M. Bencsik, J. Peng, T. D. Nguyen, C. Manalac, B. P. Halloran, B. R. Conklin, and R. A. Nissenson From the Cover: Osteoblast expression of an engineered Gs-coupled receptor dramatically increases bone mass PNAS, January 29, 2008; 105(4): 1209 - 1214. [Abstract] [Full Text] [PDF]

				J. Bollerslev, S. Jansson, C. L. Mollerup, J. Nordenstrom, E. Lundgren, O. Torring, J.-E. Varhaug, M. Baranowski, S. Aanderud, C. Franco, et al. Medical Observation, Compared with Parathyroidectomy, for Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized Trial J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1687 - 1692. [Abstract] [Full Text] [PDF]